DA
Therapeutic Areas
ProQR Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| AX-0810 | Undisclosed rare disease | Pre-clinical/Phase 1 |
| Eli Lilly Collaboration Programs | Neurological and cardiometabolic disorders | Discovery/Pre-clinical |
| Drug | Indication | Phase |
|---|---|---|
| AX-0810 | Undisclosed rare disease | Pre-clinical/Phase 1 |
| Eli Lilly Collaboration Programs | Neurological and cardiometabolic disorders | Discovery/Pre-clinical |